Sanofi and Regeneron IL-6 Receptor Antibody Gets Approval In Canada

News   Feb 06, 2017 | Original Story From Sanofi

 
Sanofi and Regeneron IL-6 Receptor Antibody Gets Approval In Canada
 
 
 
 

RELATED ARTICLES

Freedom of Information Request Reveals Benefits of Blocked MS Drug

News

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

READ MORE

Are Stem Cells the Link Between Bacteria and Cancer?

News

New mechanism of stomach gland regeneration reveals impact of Helicobacter pylori infection.

READ MORE

Why Combining Two Checkpoint Inhibitors is More Effective Than Using Them in Isolation

News

A team at the MD Anderson Cancer center team has found that checkpoint inhibitors fire up different types of T cells to attack tumors

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE